新天药业

贵阳新天药业股份有限公司创建于1995年8月，2017年5月19日在深圳证券交易所中小企业板上市交易，股票简称：新天药业，股票代码：002873。公司属于医药制造业的中成药生产行业，拥有通过GMP认证的硬胶囊剂、合剂、颗粒剂、凝胶剂、片剂、糖浆剂、酒剂、露剂等八个剂型生产线及中药饮片A线、B线两条饮片生产线。主要从事泌尿系统疾病类、妇科类及其他病因复杂类疾病用药的中成药产品研究开发、生产与销售，为患者提供安全、有效的产品。

Zhejiang Jolly Pharmaceutical Co Ltd, established in 1995 and listed on Shenzhen Stock Exchange in 2011, mainly focuses on R&D, production and sale of traditional Chinese Medicines, including Wuling powder, tablets, capsules, granules and freeze-dried powders.In September 2014, Zhejiang Jolly Pharmaceutical signed an investment agreement with the former shareholders of Zhejiang Kaixin Medicine to acquire 47.5% stock right of Kaixin Medicine for RMB 12 million (US $1.95 million) and simultaneously use cash for a capital increase. The price of the capital increase was to be RMB 1 (US $0.16) capital contribution to RMB 2.4 (US $0.39) and the amount of capital increment would be RMB 12 million (US $1.95 million). After completion of the transaction, Jolly Pharmaceutical would hold 65% of Kaixin Medcine. The acquisition and capital increase was expected to be RMB 24 million (US $3.90 million) in total.In June 2014, Zhejiang Jolly Pharmaceutical announced that trading of its shares was suspended from

贵阳新天药业股份有限公司创建于1995年8月，2017年5月19日在深圳证券交易所中小企业板上市交易，股票简称：新天药业，股票代码：002873。公司属于医药制造业的中成药生产行业，拥有通过GMP认证的硬胶囊剂、合剂、颗粒剂、凝胶剂、片剂、糖浆剂、酒剂、露剂等八个剂型生产线及中药饮片A线、B线两条饮片生产线。主要从事泌尿系统疾病类、妇科类及其他病因复杂类疾病用药的中成药产品研究开发、生产与销售，为患者提供安全、有效的产品。